These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37001883)

  • 1. Biology of Precancers and Opportunities for Cancer Interception: Lesson from Colorectal Cancer Susceptibility Syndromes.
    Monahan KJ; Swinyard O; Latchford A
    Cancer Prev Res (Phila); 2023 Aug; 16(8):421-427. PubMed ID: 37001883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
    Stone JK; Mehta NA; Singh H; El-Matary W; Bernstein CN
    Fam Cancer; 2023 Oct; 22(4):413-422. PubMed ID: 37119510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular rationale for the how, when and why of colorectal cancer screening.
    Souza RF
    Aliment Pharmacol Ther; 2001 Apr; 15(4):451-62. PubMed ID: 11284773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention in hereditary colorectal cancer syndromes.
    Hawk E; Lubet R; Limburg P
    Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention Considerations in Patients with Hereditary Colorectal Cancer Syndromes.
    Macaron C; Mankaney GN; Haider M; Mouchli M; Hurley K; Burke CA
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):131-146. PubMed ID: 34798982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
    Asano TK; McLeod RS
    Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib as adjunctive therapy for treatment of colorectal cancer.
    North GL
    Ann Pharmacother; 2001 Dec; 35(12):1638-43. PubMed ID: 11793634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.
    Yamano T; Hamanaka M; Babaya A; Kimura K; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Matsubara N; Tomita N; Sugihara K
    Cancer Sci; 2017 Feb; 108(2):243-249. PubMed ID: 27870147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
    Al-Sukhni W; Aronson M; Gallinger S
    Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Colorectal Cancer in Hereditary Syndromes.
    Cunningham LA; Gasior A; Kalady MF
    Surg Oncol Clin N Am; 2022 Apr; 31(2):307-319. PubMed ID: 35351280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and familial adenomatous polyposis: coming full circle.
    Chan AT
    Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.
    Mraz KA; Hodan R; Rodgers-Fouche L; Arora S; Balaguer F; Guillem JG; Jeter JM; Kanth P; Li D; Liska D; Melson J; Perez K; Ricker C; Shirts BH; Vilar E; Katona BW; Dominguez-Valentin M
    Front Oncol; 2023; 13():1141810. PubMed ID: 37293588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Smith KD; Rodriguez-Bigas MA
    Surg Oncol Clin N Am; 2009 Oct; 18(4):705-15. PubMed ID: 19793576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.